CD8(+) T cells are very important in cancer immunotherapy because they produce IFNγ, which activates the STAT1 signalling pathway, inhibits SLC7A11 expression and induces ferroptosis in tumour cells.39 This evidence concerns the gene IFNG and neoplasm.